India’s Piramal Ropes In Big Pharma Heavyhitters To Support Late-Stage R&D
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - A progressively maturing pipeline of innovative compounds has led Piramal Healthcare Ltd. to begin adding leadership positions to its core research team. Piramal is believed to be drawing senior-level executives from established global companies in functions like drug discovery, development, international regulatory affairs and marketing strategies to ramp up expertise in late-stage processes